Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Purple Innovation (PRPL) Cash & Equivalents (2017 - 2025)

Historic Cash & Equivalents for Purple Innovation (PRPL) over the last 9 years, with Q3 2025 value amounting to $32.4 million.

  • Purple Innovation's Cash & Equivalents rose 3846.75% to $32.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $32.4 million, marking a year-over-year increase of 3846.75%. This contributed to the annual value of $29.0 million for FY2024, which is 802.03% up from last year.
  • As of Q3 2025, Purple Innovation's Cash & Equivalents stood at $32.4 million, which was up 3846.75% from $34.2 million recorded in Q2 2025.
  • Over the past 5 years, Purple Innovation's Cash & Equivalents peaked at $110.1 million during Q2 2021, and registered a low of $21.6 million during Q1 2025.
  • Moreover, its 5-year median value for Cash & Equivalents was $34.5 million (2024), whereas its average is $48.8 million.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first soared by 29356.66% in 2021, then tumbled by 6260.12% in 2022.
  • Purple Innovation's Cash & Equivalents (Quarter) stood at $91.6 million in 2021, then plummeted by 54.42% to $41.8 million in 2022, then tumbled by 35.68% to $26.9 million in 2023, then rose by 8.02% to $29.0 million in 2024, then increased by 11.68% to $32.4 million in 2025.
  • Its Cash & Equivalents stands at $32.4 million for Q3 2025, versus $34.2 million for Q2 2025 and $21.6 million for Q1 2025.